跳至主要内容
临床试验/NCT06029192
NCT06029192招募中不适用

Diastolic Function in Myotonic Dystrophy Type 1

Centre d'Investigation Clinique et Technologique 8051 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2023年6月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
mortality

研究概览

简要总结

Myotonic dystrophy type 1 (DM1) is a neuromuscular disorder in relation with an unstable expansion of CTG repeat. Patients with DM1 are at risk of arrhythmia and conduction disorders. Mortality are mainly related to respiratory failure and sudden death. Patients with DM1 may suffer from obesity, arterial hypertension, diabetes mellitus and sleep apnea. These comorbidities are classically associated with left ventricular diastolic dysfunction (DD) .

The investigators aim to assess the prevalence of left ventricular diastolic dysfunction in patients with myotonic dystrophy type 1 , the distribution of DD grading as well as the long-term prognosis of DM1 patients with a left ventricular diastolic dysfunction.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with genetic proven myotonic dystrophy type 1
  • who experienced a Doppler- Echocardiography including an assessment of the left ventricular diastolic function

排除标准

  • wall motion basal abnormalities
  • significant valvular disease

结局指标

主要结局

mortality

时间窗: 7 years

次要结局

  • Incidence of arrhythmia(7 years)
  • acute heart failure(7 years)

研究者

发起方
Centre d'Investigation Clinique et Technologique 805
申办方类型
Other
责任方
Principal Investigator
主要研究者

Abdallah FAYSSOIL

Associate Professor

Centre d'Investigation Clinique et Technologique 805

研究点 (1)

Loading locations...

相似试验